OACCNasdaqBlank ChecksFiscal year ends December 31Also trades as OACCU, OACCW

Oaktree Acquisition Corp. III Life Sciences

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026

$10.65−0.05 (-0.47%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

Oaktree Acquisition Corp. III Life Sciences cash flow statement

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q3 2024 2024-09-30
Operating Cash Flow	-0.10	-0.16	-0.14	-0.06	-0.15	-0.08	0
Investing Cash Flow	–	–	0.25	0	–	–	0

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -113.5%

Financial strength

Current ratio: 0.73
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 68.2%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –